Pathophysiology of Acute Liver Failure.
Dong V, Nanchal R, Karvellas CJ.
Nutr Clin Pract. 2020 Feb;35(1):24-29. doi: 10.1002/ncp.10459. Epub 2019 Dec 15.
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review.
Armenian P, Vo KT, Barr-Walker J, Lynch KL.
Neuropharmacology. 2018 May 15;134(Pt A):121-132. doi: 10.1016/j.neuropharm.2017.10.016. Epub 2017 Oct 14.
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.
Ciccarone D.
Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350. doi: 10.1097/YCO.0000000000000717.
Naloxone.
Handal KA, Schauben JL, Salamone FR.
Ann Emerg Med. 1983 Jul;12(7):438-45. doi: 10.1016/s0196-0644(83)80343-6.
Designer drugs – still a threat?
Rozenek EB, Wilczyńska K, Górska M, Waszkiewicz N.
Przegl Epidemiol. 2019;73(3):337-347. doi: 10.32394/pe.73.23.
Blood concentrations of new synthetic opioids.
Adamowicz P, Nowak K.
Int J Legal Med. 2022 Jan;136(1):107-122. doi: 10.1007/s00414-021-02729-2. Epub 2021 Oct 22.
Newly Emerging Drugs of Abuse.
Tamama K, Lynch MJ.
Handb Exp Pharmacol. 2020;258:463-502. doi: 10.1007/164_2019_260.
U-47700: A Clinical Review of the Literature.
Rambaran KA, Fleming SW, An J, Burkhart S, Furmaga J, Kleinschmidt KC, Spiekerman AM, Alzghari SK.
J Emerg Med. 2017 Oct;53(4):509-519. doi: 10.1016/j.jemermed.2017.05.034. Epub 2017 Sep 12.
Cost-Effectiveness of Biosimilars vs Leflunomide in Patients With Rheumatoid Arthritis.
Peng K, Chan SCW, Wang Y, Cheng FWT, Yeung WWY, Jiao Y, Chan EWY, Wong ICK, Lau CS, Li X.
JAMA Netw Open. 2024 Jun 3;7(6):e2418800. doi: 10.1001/jamanetworkopen.2024.18800.
The Impact of Opioids on Cardiac Electrophysiology.
Wedam EF, Haigney MC.
Curr Cardiol Rev. 2016;12(1):27-36. doi: 10.2174/1573403x1201160126122405.
